Citation:Bikhchandani J, Wood J, Richards AT, Smith RB 2014

Citation

Bikhchandani J, Wood J, Richards AT, Smith RB. No benefit in staging fluorodeoxyglucose-positron emission tomography in clinically node-negative head and neck cutaneous melanoma. Head Neck 2014 Sep;36(9):1313-6 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23956077.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Bikhchandani J, Wood J, Richards AT, Smith RB 2014	What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic stage I and stage II patients?	Lyndal Alchin	completed
Bikhchandani J, Wood J, Richards AT, Smith RB 2014 2	What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic stage I and stage II patients?	Tamsin Parrish	completed

Compare quality appraisals for each clinical question

• [[Clinical question:What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic Stage I and II patients?|]] (compare critical appraisals)
• [[Clinical question:What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic Stage I and II patients?|]] (compare critical appraisals)

Cited by

1. What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic stage I and stage II patients?